Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research7/2/2026Positive
ZBH
Zimmer Biomet Holdings IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$17.02B
P/E Ratio
22.79
EPS
$3.86
Beta
0.46
52W High
$107.16
52W Low
$78.91
50-Day MA
$85.89
200-Day MA
$91.73
Dividend Yield
1.07%
Profit Margin
9.05%
Forward P/E
10.75
PEG Ratio
0.64
About Zimmer Biomet Holdings Inc
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Fundamentals
| Revenue (TTM) | $8.41B |
| Gross Profit (TTM) | $5.90B |
| EBITDA | $2.58B |
| Operating Margin | 19.70% |
| Return on Equity | 6.07% |
| Return on Assets | 4.10% |
| Revenue/Share (TTM) | $42.68 |
| Book Value | $65.53 |
| Price-to-Book | 1.37 |
| Price-to-Sales (TTM) | 2.02 |
| EV/Revenue | 2.903 |
| EV/EBITDA | 10.58 |
| Quarterly Earnings Growth (YoY) | 34.10% |
| Quarterly Revenue Growth (YoY) | 9.30% |
| Shares Outstanding | $193.46M |
| Float | $192.93M |
| % Insiders | 0.15% |
| % Institutions | 106.35% |
Historical Volatility
HV 10-Day
49.09%
HV 20-Day
38.15%
HV 30-Day
32.91%
HV 60-Day
38.04%
HV Rank
76.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($98.20 target)
2
Strong Buy6
Buy17
Hold1
SellLatest News
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal
PCRX is set to sell its iovera franchise to ZBH in a deal worth up to $140M as it sharpens focus on biopharmaceutical growth.
Zacks Investment Research7/1/2026Neutral
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.
Zacks Investment Research6/24/2026Positive
Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research6/18/2026Positive
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research6/16/2026Positive
Zimmer Biomet: Does Slow And Steady Still Win The Race?
Zimmer Biomet Holdings trades at a steep valuation discount despite strong free cash flow and high margins. ZBH's entrenched position in orthopedic implants, robust cash generation, and loyal installed base underpin reliable earnings. Recent results show net sales up 9.3%, adjusted EPS up 15.5%, and adjusted gross margin rising to 73.0%.
Seeking Alpha6/16/2026Positive
Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research5/28/2026Positive
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
WARSAW, Ind., May 22, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2026.
PRNewsWire5/22/2026Neutral
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research5/18/2026Positive
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?
Abbott vs. Zimmer Biomet: surgical equipment stocks face diverging growth, acquisitions, and valuation shifts as investors weigh momentum and margins.
Zacks Investment Research5/18/2026Positive
More HEALTHCARE Stocks
Data last updated: 7/9/2026